I. Joye

发表

International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Karin Haustermans, Vincenzo Valentini, Claudio Coco, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.

M. Peeters, E. Smits, H. Prenen, 2020, Critical reviews in oncology/hematology.

Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer

K. Haustermans, I. Joye, Cedric Stuyck, 2017, Acta oncologica.

Early and late toxicity of radiotherapy for rectal cancer.

K. Haustermans, I. Joye, 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer.

Olivier Gevaert, Karin Haustermans, Mu Zhou, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Can medical imaging identify the histopathological growth patterns of liver metastases?

C. Vanhove, P. van Dam, P. Vermeulen, 2020, Seminars in cancer biology.

The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic

P. Vermeulen, L. Dirix, D. Verellen, 2020, Radiotherapy and Oncology.

Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study

A. Debucquoy, K. Haustermans, E. Van Cutsem, 2022, Clinical and translational radiation oncology.

Implementation of volumetric modulated arc therapy for rectal cancer: Pitfalls and challenges

K. Haustermans, T. Depuydt, I. Joye, 2015, Acta oncologica.

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

C. Desmedt, I. Nagtegaal, M. D'Angelica, 2022, British journal of cancer.

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables

D. Verellen, P. Dirix, C. Billiet, 2022, Physics and imaging in radiation oncology.

Stereotactic ablative radiation therapy to all lesions in patients with oligometastatic cancers: a phase I dose-escalation trial.

P. Vermeulen, L. Dirix, S. V. van Laere, 2020, International journal of radiation oncology, biology, physics.

The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.

B. Heijmen, K. Muller, H. Ceha, 2020, International journal of radiation oncology, biology, physics.

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights

C. Desmedt, I. Nagtegaal, M. D'Angelica, 2022, British Journal of Cancer.

Response Assessment

P. Dirix, I. Joye, 2019, MRI for Radiotherapy.

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

P. Vermeulen, D. Verellen, Y. Lievens, 2019, BMC Cancer.

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases

P. Vermeulen, S. V. van Laere, D. Verellen, 2020, Clinical and translational radiation oncology.

Which Patients With Rectal Cancer Do Not Need Radiotherapy?

K. Haustermans, I. Joye, 2016, Seminars in radiation oncology.

The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.

Karin Haustermans, Vincent Vandecaveye, K. Haustermans, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison.

G. Silversmit, A. Debucquoy, K. Haustermans, 2016, Cancer epidemiology.

When Should IGRT Be Done

K. Haustermans, I. Joye, 2018 .

Clinical target volume delineation for rectal cancer radiation therapy: time for updated guidelines?

K. Haustermans, I. Joye, 2015, International journal of radiation oncology, biology, physics.

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

P. Vermeulen, D. Verellen, Y. Lievens, 2019, BMC Cancer.

Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer?

Steffen Fieuws, Karin Haustermans, A. Debucquoy, 2016, Acta oncologica.

Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature.

M. Guckenberger, Y. Lievens, I. Kindts, 2022, International Journal of Radiation Oncology, Biology, Physics.

Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project.

K. Haustermans, P. Scalliet, I. Joye, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long term results of a phase I dose escalation trial of ablative stereotactic body radiation therapy.

P. Ost, P. Dirix, C. Billiet, 2023, International journal of radiation oncology, biology, physics.